Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
66,359,568
-
Shares change
-
+4,583,335
-
Total reported value, excl. options
-
$336,444,770
-
Value change
-
+$26,875,848
-
Put/Call ratio
-
68%
-
Number of buys
-
76
-
Number of sells
-
53
-
Price
-
$5.07
Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q2 2025
As of 30 Jun 2025 aTYR PHARMA INC - COMMON STOCK (ATYR) had 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 66,359,568 shares of stock of the company.
Largest 10 holders included FEDERATED HERMES, INC., FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Octagon Capital Advisors LP, Tikvah Management LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Woodline Partners LP, and MILLENNIUM MANAGEMENT LLC.
This table shows 151 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.